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There are two conceptually divergent streams of 
therapeutic modules operative in India today both 
being vibrant. These modules are operative on one 
hand in the modern hospitals as Allopathic system and 
the other being scattered in the country especially in 
the rural parts as Ayurvedic, Sidha and Unani and to 
an extent the century and half old Homeopathic 
systems. This review is to probe the possibility of 
converging the conceptually different systems under a 
single roof of modern hospital, the rendezvous 
achieved by the role of a Clinical Pharmacognosist 
who could bridge the gap between both the systems. 
The concept has been pushed on for the last decade 
and half by way of scientific articles and presentations 
by the author. There are several instances- especially 
in the southern India that many modern hospitals 
maintain a holistic wing without any clinical 
interaction of give and take. It is vital to operate both 
the systems complimentarily keeping their own idiom 
intact in the presence of Physicians of both the 
systems who are linked by Clinical Pharmacognosist 
in the hospital environment. 
 
The idiomatic divergence of systems: 
Let us on the outset, focus on the Holistic systems of 
Indian therapy and its modus operandi. Holism is a 
concept of looking into „macrocosm‟ not anyway 
atypical from „microcosm‟ (universe to atom 
structurally) and look up on human body as an 
institution in personage rather than break up 
appendages. In other words, the thrust area of 
treatment is on the Patient rather than on the disease. 
For the very reason, there is no concept of fixed 
formulation or bulk manufacture in Traditional 
practice. But this concept is slowly being eroded 
alarmingly for their own reasons of increase in out-
patient numbers and dispensing complexities that 
follow after diagnosis. The variation in standards of 
formulations is felt significantly in recent times which 
makes it urgent to bring the dispensing under the 
credentials of a Clinical Pharmacognosist in the 
hospital environment with documentation of the 
clinical findings. More than 60% of Indian population 
according to WHO is still dependent on the traditional 
therapy like Ayurveda, Sidha, Unani and tribal 
systems along with more or less recently adopted 
Homeopathic practice. They are practiced in India 
with flexibility depending on the ethnic diversification 
in life styles and regionally accessible natural products 
and Practitioners. The Ayurveda, for instance an 
„anga‟ or segment of Atharvaveda, has been constantly 
interpreted by Charaka, Susruta, Vagbhata and 
Nagarjuna [of post Buddha period introducing 
metallurgy] and a host of others through ages. The 
systems have been subjected to constant churning 
process to suit the needs of changing era and 
revitalised without changing its basic idiom, and is 
still vibrant. Many formulations, especially bhasma 
(incinerated ash of metallic combinations) are 
subjected in recent times for its property of nano size 
particles and understanding more on the mechanism of 
action through free radical control.  Sidha system 
developed as a regional style practiced more 
predominantly in Southern coastal area of Tamil Nadu 
with the migration of Saint Agastya, the migratory 
phenomenon being the explicate cause in proliferating 
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and bartering the country-wide practice to ethnic 
regional variation. The Mesopotamian and Egyptian 
pre-Islamic culture of therapy, which interacted with 
both Indian and Greek ancient systems at a point of 
time, came to India during post Islamic period as 
Unani through hakims and got well ingrained to the 
Indian system. Avicenna‟s “Canon of Medicine” was 
popular equally in Europe as a text book until 17th 
century as well as in India especially during Mugal 
periods. 
 
Evolution of Modern Allopathic system 
The modern Allopathic system, as generally conceived 
is not a descendant from the ancient Greek system, but 
originated in the medieval Europe. The apothecary 
concept of a person who engaged himself in diagnosis 
and dispensing of medicament was almost a holistic 
practice to start with. The industrial revolution and the 
fast rate of scientific momentum by way of research 
paved way to treat diseases deviating from the holistic 
patient consideration. It was precisely in 1803 AD that 
Derosne a French apothecary for the first time isolated 
an alkaloid molecule narcotine from opium.  
Subsequently, many molecules were isolated from 
plant materials. This opened a new arena of therapy at 
molecular level. The isolation from natural products 
further led to synthesis of molecules, and a large 
number of potent molecules in the present day market 
are arranged in therapeutic index based on 
Pharmacological action as anti-biotics, anti-
histaminics, anti-pyretics, anti-inflammatory, anti-
hypertensive, etc.  
The modern allopathic research on new 
molecules start from theory, then goes to 
isolation/synthesis and practical experiments on 
animals for structure related activity and finally on 
different phases of clinical trials before a drug is put in 
the market. The holistic system, on the other hand 
begins from experience, and observation on a 
particular patient, and proceeding to hypothesis and 
arrive at the holistic formulations after the diagnosis 
and then goes for formulations. „Pathya‟ or restrictions 
on food and life-routine and to be in a state of 
gratitude and faith as part of ethics are also part of 
treatment. In my experience of such subjective 
scattered therapeutic results, most of them go 
undocumented where the role of Clinical 
Pharmacognosist becomes relevant. 
 
Conclusion 
When two diverse systems of therapy continue to exist 
in a country and clinical results of one of the systems 
go undocumented, there is an urgent necessity for 
documentation of the same through a single window. 
Clinical Pharmacognosist has an important role to 
bridge the gap between the systems in a hospital 
environment. Pharm.D program of a country with a 
tradition behind has a potential task to perform in 
order to bring home the positive aspects of subjective 
clinical trials of traditional therapy. In a continuing 
education program if past is wealth and resources, 
today is the utilization using the available modern 
technology looking forward for a target 2020 A.D. 
 
